Can targeting the incretin pathway dampen RAGE-mediated events in diabetic nephropathy
Bregman believes the FDA's action is overdue, as it will likely lead to a crackdown on compounders and affect 1.5 million users of compounded drugs
Feb 11, 2026 Semaglutide and tirzepatide look almost identical on paper
Observed side effects in research settings are generally mild and may include temporary nausea-related observations, flushing-related observations, headache-related observations, fatigue-related observations, administration-site irritation, pigmentation variability, pigmentation variability involving freckles or moles, and temporary appetite-related response variability depending on research amount, UV exposure, administration frequency, skin type, and individual physiological sensitivity